Pathogenesis of enterotropic mouse hepatitis virus in immunocompetent and immunodeficient mice.
Mouse hepatitis virus (MHV) is one of the most prevalent viruses infecting laboratory mice. Most natural infections are caused by enterotropic strains. Experiments were done to compare the pathogenesis of enterotropic strain MHV-Y in immunocompetent BALB/c and C57BL/6 mice with that in B and T cell-deficient mice. In situ hybridization was used to identify sites of virus replication, and reverse transcriptase-polymerase chain reaction analysis was used to detect viral RNA in feces and blood. MHV-Y caused acute subclinical infections restricted to the gastrointestinal tract in BALB/c and C57BL/6 mice. Viral RNA was detected in small intestine and associated lymphoid tissues of immunocompetent mice for 1 week and in cecum and colon for 2 weeks. Infected B cell-deficient mice developed chronic subclinical infection also restricted to the gastrointestinal tract. Viral RNA was detected in the small intestine, cecum, colon, and feces for 7 to 8 weeks. In contrast, infected T cell-deficient mice developed multisystemic lethal infection. During the first week, viral RNA was restricted to the gastrointestinal tract. However, by 2 weeks, mice developed peritonitis, and viral RNA was detected in mesentery and visceral peritoneum. Three to four weeks after virus inoculation, T cell-deficient mice became moribund and viral RNA was detected in multiple organ systems. These results suggest that B cells promote clearance of MHV-Y from intestinal mucosa and that T cells are required to prevent dissemination of MHV-Y from the gastrointestinal tract and associated lymphoid tissues.
Compton
Susan R
SR
Section of Comparative Medicine, Yale University School of Medicine, New Haven, Connecticut 06520-8016, USA.
Ball-Goodrich
Lisa J
LJ
Johnson
Linda K
LK
Johnson
Elizabeth A
EA
Paturzo
Frank X
FX
Macy
James D
JD
D000818:Animals; D001402:B-Lymphocytes / Q000276:immunology; D018352:Coronavirus Infections / Q000209:etiology* / Q000276:immunology*; D005260:Female; D006524:Hepatitis, Viral, Animal / Q000209:etiology* / Q000276:immunology*; D007121:Immunocompetence; D007153:Immunologic Deficiency Syndromes / Q000150:complications / Q000276:immunology; D017403:In Situ Hybridization; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D008817:Mice, Mutant Strains; D006517:Murine hepatitis virus / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification / Q000472:pathogenicity*; D012367:RNA, Viral / Q000235:genetics / Q000302:isolation & purification; D013045:Species Specificity; D013601:T-Lymphocytes / Q000276:immunology
D012367:RNA, Viral